✦ LIBER ✦

Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β

✍ Scribed by Hexiao Tang, Yongde Liao, Guang Chen, Liqiang Xu, Chao Zhang, Sheng Ju, Sheng Zhou

Book ID: 118821592
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 483 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-012-0198-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Crosstalk Between IGF1R and Estrogen Rec

Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer

✍ Dedra H. Fagan; Douglas Yee 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 165 KB

17 β-estradiol and tamoxifen upregulate

17 β-estradiol and tamoxifen upregulate estrogen receptor β expression and control podocyte signaling pathways in a model of type 2 diabetes

✍ Catanuto, Paola; Doublier, Sophie; Lupia, Enrico; Fornoni, Alessia; Berho, Maria 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 348 KB

The relationships between snail1 and est

The relationships between snail1 and estrogen receptor signaling in breast cancer cells

✍ Alexander M. Scherbakov; Olga E. Andreeva; Valentina A. Shatskaya; Mikhail A. Kr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

Sex Steroids Upregulate the IGF-1R in Pr

Sex Steroids Upregulate the IGF-1R in Prostate Cancer Cells through a Nongenotropic Pathway

✍ Giuseppe Pandini; Marco Genua; Francesco Frasca; Riccardo Vigneri; Antonino Belf 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Expression, Function, and Clinical Impli

Expression, Function, and Clinical Implications of the Estrogen Receptor β in Human Lung Cancers

✍ Yoko Omoto; Yasuhito Kobayashi; Kazunori Nishida; Eiju Tsuchiya; Hidetaka Eguchi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 373 KB

Bidirectional interactions between the e

Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells

✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/